Lucila Nassif Kerbauy

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

Enli Liu, David Marín, Pinaki P. Banerjee et al. · New England Journal of Medicine · 2020 · 2K citations · Full text

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

May Daher, Rafet Başar, Elif Gokdemir et al. · Blood · 2020 · 272 citations · Full text

Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells

Hila Shaim, Mayra Shanley, Rafet Başar et al. · Journal of Clinical Investigation · 2021 · 234 citations · Full text

Cell Therapy, Immunology, Immune Regulation +28

KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

Ye Li, Rafet Başar, Guohui Wang et al. · Nature Medicine · 2022 · 152 citations · Full text

Natural Killer Cells, Immunology, Tumor Escape +10

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

Lucila Nassif Kerbauy, Nancy D. Marín, Mecit Kaplan et al. · Clinical Cancer Research · 2021 · 147 citations · Full text